Cargando…

Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.

BACKGROUND: In the local Malaysian context, herbal plants such as Eurycoma longifolia (Tongkat Ali), Orthosiphon stamineus (MisaiKucing), Ficus deltoidea (Mas Cotek), Zingiber officinale (Halia Bara) and Barringtonia racemosa (Putat) are known and widely used for its therapeutic properties. The firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Girish, Sonal, Kumar, Suresh, Aminudin, Norhaniza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476169/
https://www.ncbi.nlm.nih.gov/pubmed/26082155
http://dx.doi.org/10.1186/s13071-015-0942-y
_version_ 1782377562566033408
author Girish, Sonal
Kumar, Suresh
Aminudin, Norhaniza
author_facet Girish, Sonal
Kumar, Suresh
Aminudin, Norhaniza
author_sort Girish, Sonal
collection PubMed
description BACKGROUND: In the local Malaysian context, herbal plants such as Eurycoma longifolia (Tongkat Ali), Orthosiphon stamineus (MisaiKucing), Ficus deltoidea (Mas Cotek), Zingiber officinale (Halia Bara) and Barringtonia racemosa (Putat) are known and widely used for its therapeutic properties. The first part of this study aims to screen for the anti-protozoal activity of these herbal plant extracts against Blastocystis sp. isolate subtype (ST) 3. Herbal extract with the highest efficacy was further fractionized into water and ethyl acetate fractions and tested against ST1, ST3 and ST5 Blastocystis sp. isolates. These isolates were also exposed to allopathic drugs, Metronidazole (MTZ), Tinidazole, Trimethoprim-sulfamethoxazole(TMP-SMX), Ketoconazole and Nitazoxanide for comparison purpose. METHODS: Blastocystis sp. isolates from human-derived stool samples were exposed to herbal extracts and allopathic drugs at a concentration of 0.1 mg/ml and 1.0 mg/ml and were incubated at 37 °C. Growth profile studies were carried out. After 72 h of treatment, the viability of Blastocystis sp. as a result of the effects of the drugs and herbal extracts were assessed. RESULTS: Based on the screening process, amongst all the extracts, Tongkat Ali exhibited the highest anti-protozoal activity at 1.0 mg/ml. Between the water and ethyl acetate fractions of Tongkat Ali, the ethyl acetate fraction exhibited a slightly higher percentage of anti-protozoal activity at 1.0 mg/ml across subtypes, ST1 (94.9 %), ST3 (95.1 %) and ST5 (94.3 %). When tested with allopathic drugs, at the same concentration, MTZ exhibited the highest anti-protozoal activity across subtypes, ST1 (95.8 %), ST3 (93.4 %) and ST5 (90.8 %). CONCLUSION: This study is the first to describe the anti-protozoal properties of Tongkat Ali against Blastocystis sp. isolates. Ethyl acetate fraction of Tongkat Ali demonstrated the highest anti-protozoal activity against Blastocystis sp. isolates and showed a sizeable reduction in the cell count which was comparable with MTZ. Tongkat Ali also demonstrated a more uniformed sensitivity across subtypes in comparison to the allopathic drugs.
format Online
Article
Text
id pubmed-4476169
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44761692015-06-23 Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. Girish, Sonal Kumar, Suresh Aminudin, Norhaniza Parasit Vectors Research BACKGROUND: In the local Malaysian context, herbal plants such as Eurycoma longifolia (Tongkat Ali), Orthosiphon stamineus (MisaiKucing), Ficus deltoidea (Mas Cotek), Zingiber officinale (Halia Bara) and Barringtonia racemosa (Putat) are known and widely used for its therapeutic properties. The first part of this study aims to screen for the anti-protozoal activity of these herbal plant extracts against Blastocystis sp. isolate subtype (ST) 3. Herbal extract with the highest efficacy was further fractionized into water and ethyl acetate fractions and tested against ST1, ST3 and ST5 Blastocystis sp. isolates. These isolates were also exposed to allopathic drugs, Metronidazole (MTZ), Tinidazole, Trimethoprim-sulfamethoxazole(TMP-SMX), Ketoconazole and Nitazoxanide for comparison purpose. METHODS: Blastocystis sp. isolates from human-derived stool samples were exposed to herbal extracts and allopathic drugs at a concentration of 0.1 mg/ml and 1.0 mg/ml and were incubated at 37 °C. Growth profile studies were carried out. After 72 h of treatment, the viability of Blastocystis sp. as a result of the effects of the drugs and herbal extracts were assessed. RESULTS: Based on the screening process, amongst all the extracts, Tongkat Ali exhibited the highest anti-protozoal activity at 1.0 mg/ml. Between the water and ethyl acetate fractions of Tongkat Ali, the ethyl acetate fraction exhibited a slightly higher percentage of anti-protozoal activity at 1.0 mg/ml across subtypes, ST1 (94.9 %), ST3 (95.1 %) and ST5 (94.3 %). When tested with allopathic drugs, at the same concentration, MTZ exhibited the highest anti-protozoal activity across subtypes, ST1 (95.8 %), ST3 (93.4 %) and ST5 (90.8 %). CONCLUSION: This study is the first to describe the anti-protozoal properties of Tongkat Ali against Blastocystis sp. isolates. Ethyl acetate fraction of Tongkat Ali demonstrated the highest anti-protozoal activity against Blastocystis sp. isolates and showed a sizeable reduction in the cell count which was comparable with MTZ. Tongkat Ali also demonstrated a more uniformed sensitivity across subtypes in comparison to the allopathic drugs. BioMed Central 2015-06-18 /pmc/articles/PMC4476169/ /pubmed/26082155 http://dx.doi.org/10.1186/s13071-015-0942-y Text en © Girish et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Girish, Sonal
Kumar, Suresh
Aminudin, Norhaniza
Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
title Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
title_full Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
title_fullStr Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
title_full_unstemmed Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
title_short Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
title_sort tongkat ali (eurycoma longifolia): a possible therapeutic candidate against blastocystis sp.
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476169/
https://www.ncbi.nlm.nih.gov/pubmed/26082155
http://dx.doi.org/10.1186/s13071-015-0942-y
work_keys_str_mv AT girishsonal tongkatalieurycomalongifoliaapossibletherapeuticcandidateagainstblastocystissp
AT kumarsuresh tongkatalieurycomalongifoliaapossibletherapeuticcandidateagainstblastocystissp
AT aminudinnorhaniza tongkatalieurycomalongifoliaapossibletherapeuticcandidateagainstblastocystissp